Home > Products > EGFR & MET
> Anti-EGFR x Anti-MET Bispecific Antibody (IgG-IgG)
Anti-EGFR x Anti-MET Bispecific Antibody (IgG-IgG) (CAT#: BSIG-154)
Anti-EGFR x Anti-MET Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-EGFR and anti-MET parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Anti-EGFR x Anti-MET Bispecific Antibody (IgG-IgG) (BSIG-154). Click the button below to contact us or submit your feedback about this product.